Nomura Holdings Inc. Purchases 28,231 Shares of PetIQ, Inc. (NASDAQ:PETQ)

Nomura Holdings Inc. boosted its stake in shares of PetIQ, Inc. (NASDAQ:PETQ) by 7.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 423,496 shares of the company’s stock after buying an additional 28,231 shares during the quarter. Nomura Holdings Inc. owned approximately 1.44% of PetIQ worth $8,364,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in PETQ. ICA Group Wealth Management LLC bought a new position in shares of PetIQ in the 4th quarter worth about $35,000. DekaBank Deutsche Girozentrale acquired a new position in PetIQ in the fourth quarter valued at approximately $50,000. AJOVista LLC bought a new position in shares of PetIQ during the 4th quarter worth approximately $65,000. China Universal Asset Management Co. Ltd. grew its position in shares of PetIQ by 351.4% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 3,372 shares of the company’s stock worth $67,000 after buying an additional 2,625 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in shares of PetIQ by 1,047.9% in the 4th quarter. Tower Research Capital LLC TRC now owns 4,741 shares of the company’s stock valued at $94,000 after acquiring an additional 4,328 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on PETQ shares. Benchmark reiterated a “buy” rating and issued a $30.00 price target on shares of PetIQ in a report on Friday, May 10th. Jefferies Financial Group increased their target price on PetIQ from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, March 19th. Four analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, PetIQ has an average rating of “Buy” and a consensus target price of $29.00.

PetIQ Price Performance

PETQ opened at $22.21 on Wednesday. The company has a debt-to-equity ratio of 1.84, a current ratio of 2.42 and a quick ratio of 1.25. PetIQ, Inc. has a 1 year low of $14.20 and a 1 year high of $22.98. The stock’s 50 day simple moving average is $18.94 and its 200 day simple moving average is $18.39. The firm has a market cap of $660.75 million, a price-to-earnings ratio of 100.96 and a beta of 1.76.

PetIQ (NASDAQ:PETQ) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.17. PetIQ had a net margin of 0.66% and a return on equity of 13.33%. The business had revenue of $308.44 million for the quarter, compared to analyst estimates of $302.16 million. As a group, analysts predict that PetIQ, Inc. will post 1.09 earnings per share for the current year.

Insider Activity at PetIQ

In other news, Director Scott Huff sold 12,117 shares of PetIQ stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $22.19, for a total transaction of $268,876.23. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 9.62% of the stock is owned by corporate insiders.

PetIQ Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.